Nur Nicholson - Mar 13, 2024 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief Technical Officer
Signature
/s/ David Watson, attorney-in-fact for Nur Nicholson
Stock symbol
APLS
Transactions as of
Mar 13, 2024
Transactions value $
-$645,838
Form type
4
Date filed
3/14/2024, 04:17 PM
Previous filing
Jan 31, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale -$445K -7.77K -11.51% $57.31 59.7K Mar 13, 2024 Direct F1
transaction APLS Common Stock Sale -$201K -3.45K -5.78% $58.13 56.3K Mar 13, 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $56.91 - $57.75. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 This transaction was executed in multiple trades at prices ranging from $57.92 - $58.34. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.